Editorial · 31 Jan 2025
Mini reviewPublished 28 Feb 2024
Unlocking Hope: Advancements in Drug Development for Kidney Disease
Department of Organic Chemistry, California State University, California, U.S.A
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chronic Kidney Disease (CKD) represents a global health crisis, with profound implications for patients' quality of life and systems worldwide. Despite decades of research, treatment options for CKD have been limited, emphasizing healthcare symptom management and disease progression slowing rather than curative interventions. However, recent years have witnessed a surge of innovation and investment in drug development for kidney disease, offering renewed hope to patients and clinicians. This abstract provides a succinct overview of the latest advancements, challenges, and future prospects in drug development for kidney disease.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmacokinetics & Experimental Therapeutics.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacokinetics & Experimental Therapeutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Chris Charlotte”